(HealthDay)—Autologous hematopoietic cell transplantation (AHCT) is associated with a lower likelihood of death among adult mantle cell lymphoma (MCL) patients, but certain sociodemographic factors may affect the selection of candidates for this type of treatment, according to a study published online March 12 in Blood Advances.
